NCT06991712: Comparisons of NAD Precursors for Neuroenhancement in Glaucoma Patients
- State
- Under way
- Phase
- Phase 2
- People
- 138 planned
- Started
- 19 May 2025
- Primary completion
- 31 Dec 2025
- Arms
- Nicotinamide Riboside (Phase I)
- Results
- None posted
- 19 May 2025: Trial started
- 28 May 2025: Trial registered